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ABSTRACT 
The purpose of this study was to report the resolution of persistent Sub-Retinal Fluid (SRF) induced by subthreshold 
micropulse laser treatment in a patient, formerly treated for rhegmatogenous retinal detachment by retinal 
pneumopexy. The case was a 41-year-old male, who initially presented macula-splitting rhegmatogenous retinal 
detachment and corrected distance visual acuity of 20/40 in his left eye. He was treated by retinal pneumopexy and laser 
retinopexy. Retina was flattened and vision improved to 20/30. However, the subretinal fluid (SRF) under the fovea was 
persistently observed on repeated retinal exams. Fourteen months after the initial pneumopexy, subthreshold 
micropulse laser was applied to cover the entire area of the SRF. The improvement started two weeks afterwards and 
the SRF completely resolved within four months after the application of micropulse laser. Corrected distance visual 
acuity improved from 20/30 to 20/20, accompanied by marked improvement in patient’s complaints on visual blurriness. 
The patient was followed up for three years and no recurrence of SRF was noted. The findings of this report indicate that 
subthreshold micropulse laser may serve as a therapeutic option for persistent SRF, which may be observed after 
successful retinal detachment repair. 
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INTRODUCTION
Retinal detachment repair procedures can be followed by 
non-resolution of Subretinal Fluid (SRF), especially when 
the surgical procedure doesn’t involve internal or 
external drainage of SRF [1, 2]. Desatnik et al. identified 
the incidence of delayed SRF absorption in seven (4.3%) 
out of 160 patients, who underwent pneumatic 
retinopexy [3]. The complete resolution of SRF can take 
up to several months or even years [3, 4]. Some authors 
found that the presence of postoperative SRF might 
delay visual recovery, however, it did not seem to 
influence final visual outcome [1, 5]. Other authors 
demonstrated that persistent SRF might impose a 
detrimental effect on photoreceptors by delaying visual 
recovery and by causing structural changes in 
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photoreceptors, resulting in poorer visual prognosis and 
worse visual outcome after the complete resolution of 
SRF [4, 6-9]. It is believed that persistent SRF should be 
managed conservatively by observation [3], however, 
other therapeutic approaches [10-12] that have been 
proposed in the literature in order to expedite the 
resolution of SRF, through both safety and efficacy, 
remain unclear. Conventional laser treatment has been 
attempted in the past yet it did not seem to achieve 
immediate results [3, 13]. Subthreshold Micropulse Laser 
(MPL) was found safe and effective in many macular 
diseases, especially when used for successful absorption 
of SRF in chronic Central Serous Retinopathy (CSR), by 
inducing a biological response on Retinal Pigment 
Epithelium (RPE) cells, which promotes recovery and 
restoration of the outer blood-retinal barrier and 
accelerates the resolution of the SRF [14-19]. 
Subthreshold MPL produces therapeutic effects that 
appear comparable to those of conventional laser with 
no detectable signs of laser-induced iatrogenic damage 
[20]. The purpose of this manuscript was to report the 
outcome of MPL application for persistent SRF in a 
patient, who had been previously treated for retinal 
detachment.  
MATERIALS AND METHODS 
The case was a 41-year-old male, who initially presented 
complaints of blurry vision and nasal visual field defect in 
the left eye. The symptoms started two weeks prior to 
his referral. His ocular, systemic, and family histories 
were unremarkable, except for mild myopia. On 
presentation, Corrected Distance Visual Acuity (CDVA) 
was 20/40. The rest of anterior segment exams were 
within normal limits. On fundus examination, there was 
evidence of macula-splitting superior Rhegmatogenous 
Retinal Detachment (RRD), involving superonasal, 
superotemporal, and inferotemporal quadrants with two 
adjacent superior retinal breaks and area of lattice with 
no holes, inferiorly. Spectral Domain Optical Coherence 
Tomography (SD-OCT) (Cirrus 5000, Carl Zeiss Meditec 
Inc., Dublin, CA, USA) demonstrated SRF sub-foveally and 
central foveal retinal thickness of 553 microns. The 
patient underwent retinal pneumopexy with injection of 
0.5 cc of undiluted C3F8 (perfluoropropane) gas. Retina 
was flattened and laser retinopexy was performed 
around retinal breaks and lattice. Corrected distance 
visual acuity improved to 20/30-. However, the SRF 
under the fovea was persistently observed on his 
repeated retinal exams. The patient maintained face-
down positioning with no improvement in SRF, even after 
additional pneumopexy (0.5 cc undiluted C3F8) and laser 
retinopexy (360 degrees of laser barrage was 
completed), which were repeated after one month. 
Although his visual acuity remained stable at 20/30, the 
patient reported visual disturbance during each visit. 
During the follow-up, it was noted that persistent sub-
macular fluid had been gradually building up, yet 
repeated meticulous exams of retinal periphery under 
scleral depression on each visit showed no evidence of 
retinal defects. The treatment options, which included 
repeated pneumopexy, vitrectomy or buckle, were 
discussed with the patient on multiple occasions and the 
patient insistently refused any surgical intervention, 
despite unremitting subjective complaints of blurry vision 
in this eye. Increase in the amount of SRF was correlated 
with increase of blurry vision complaints during the 
follow-up. Subthreshold micropulse laser was offered to 
the patient. Since no subsequent head positioning was 
required and no intravitreal gas injection, preventing 
patient’s frequent travels, was needed, the patient 
expressed his willingness to undergo the procedure and 
gave informed consent, understanding the risks. 
Fourteen months after the initial pneumopexy, 
subthreshold MPL (577 nm yellow laser, Iridex IQ 577™, 
Mountain View, CA, USA) was successfully applied to 
cover the entire area of the SRF, using established 
parameters (200 micrometer spot diameter, 0.20 second 
duration, 10% duty cycle, 200 miliwatt power, 9 grids of 
7x7 pattern, and total of 441 spots). Ethical issues were 
completely observed by the author. 
RESULTS 
The improvement in SRF and clinical symptoms were 
started two weeks later and the SRF had resolved within 
four months after the application of MPL. Corrected 
distance visual acuity improved from 20/30 to 20/20, 
accompanied by marked improvement in blurriness. The 
patient was followed up for three years and no 
recurrence of SRF was noted. Longitudinal change in 
central foveal thickness during the follow-up and serial 
SD-OCT scans are presented in Fig 1 and 2. 
DISCUSSION 
The present case report described a case of successful 
resolution of persistent SRF, achieved after subthreshold 
MPL application in a patient, who had been previously 
treated for RRD. The presence of SRF after successful RD 
repair is a common finding, especially when evaluated by 
OCT, and can detect subclinical submacular fluid, 
persisting for months without being recognized on 
ophthalmoscopy [5, 21, 22]. Sub-retinal fluid is believed 
to resolve spontaneously in the majority of cases [3, 10, 
21]. However, there is evidence that apoptosis of 
photoreceptors occurs in chronic RD, suggesting that the 
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longer SRF will be present under the fovea, and the 
worse functional visual outcome might be achieved [23]. 
Micropulse laser has been reported to be effective in 
resolution of SRF in multiple retinal conditions, especially 
in patients with chronic CSR [14, 15]. It has been 
hypothesized that RPE disturbance plays an important 
role in the pathogenesis of persistent SRF formation, and 
stimulation of RPE’s pumping function may help in SRF 
absorption, without causing structural and permanent 
damage to retinal tissue [16]. 
 
Figure 1: Longitudinal Change in Central Foveal Thickness during the Follow-up 
 
Figure 2: Serial SD-OCT Scans: a) Day of Pneumopexy (PP)– 14 Months prior to Micropulse Laser (MPL), b) Two Months after PP – 12 Months prior to 
MPL, c) Six Months after PP – Eight Months prior to MPL, d) 14 Months after PP - Day of MPL, e) Two Weeks after MPL, f) Two Months after MPL, g) 
Four Months after MPL, h) 34 Months after MPL. 
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The decision of performing MPL in the presented patient 
was commanded by gradual accumulation of SRF and 
deterioration of patient’s subjective visual complaints 
while driving, working in front of the computer, reading, 
and performing other essential daily activities. Shortly 
after the MPL application, both subjective improvement 
(marked decrease in visual disturbance) and objective 
improvement (CDVA improved from 20/30 to 20/20) 
were observed. It may be speculated that visual 
improvement in this case was caused by a natural 
resolution of SRF, since the resolution of SRF may be as 
lengthy as two years. Nevertheless, the clinical course 
and dynamics of central foveal thickness changes, which 
showed gradual deterioration during the follow-up, were 
reversed by MPL. Micropulse laser treatment served a 
turning point for clinical improvement, leading to 
complete SRF resolution within several months, following 
the MPL application. Patient’s vision remained stable and 
no recurrence of SRF was observed for three years after 
the MPL application. 
CONCLUSIONS 
The use of micropulse laser for treatment of persistent 
SRF following a RD procedure resulted in complete 
resolution of the fluid and retinal reattachment. Further 
research is necessary to confirm the efficacy, safety, and 
consistency of MPL in achieving complete resolution of 
SRF in post-retinal detachment repair patients with 
persistent SRF. 
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